The Kidney TRUST
www.kidneytrust.org/new/enews/2010-11/asd-healthcare-venus-fight-kidney-disease/

ASD Healthcare’s Venus Hits the Road in the Fight Against Kidney Disease

For William Venus, the spirit and camaraderie of Tour DaVita had to be experienced to be believed.  Will, who is Vice President of Nephrology for ASD Healthcare, had heard about the Tour from colleagues who had ridden in the past, but said that the experience itself was beyond his expectations.

Will Venus, with DaVita chairman and CEO Kent Thiry and Scott Fritzley of Chapin Specialty Healthcare.

More than 400 riders participated in the 4th Annual Tour DaVita from September 18-22, 2010, embarking on a 240-mile bike ride that started in Tacoma and wound through the rainy, but scenic valleys, farms, and forests of Washington state.  Over the past four years, the Tour has raised awareness about chronic kidney disease and funds for The Kidney TRUST’s kidney disease awareness and prevention programs.

“How often do you get the chance to put day-to-day concerns aside and focus all your energy on an event that benefits a cause you believe in?” said 40-year-old Will, who is married and the father of two young girls and makes his home in Merrick, New York.  “It was rainy and wet much of the time and I should have trained more than I did, but it was a tremendously satisfying personal journey and a chance to bond with an amazing group of riders along the way.”

One of ASD Healthcare's custom bike jerseys.

In talking about the Tour, Will emphasizes how meaningful it was to him, as someone who has worked in the dialysis industry for over 15 years, to be able to get back to the essential reasons that people at companies like ASD and DaVita work as hard as they do for their patients.

“All of us at ASD are proud to be partnering with DaVita and The Kidney TRUST in the fight against this life-threatening illness,” said Will.  “Participating in the Tour was a chance for me to step back and appreciate the entire community that works together to make such a difference in the lives of people with kidney disease.”